Shares of Arix Bioscience PLC (LON: ARIX) rallied 5.4% after the venture capital firm that invests in biotech firm announced that the value of its assets had risen 62% to £328 million in December 2020 compared to the £202 million reported in 2019.
Much of the additional value was derived from the sale of its stake in VelosBio to US pharmaceutical giant Merk, which netted it £139million in tax-exempt cash. The company also revealed that its portfolio firms had some promising clinical trials on the way that could generate future returns.
Arix recently launched Twelve Bio, a biotech company developing novel engineered Cas12a nucleases for therapeutic gene editing.
Ready to put what you’ve learned into practice?
Try IG’s platform with £10,000 in virtual funds and practise trading
without putting your own money at risk.
Try IG with a demo account →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Learn the markets with IG Academy
Build your knowledge with IG Academy educational content, then use a
demo account to practise what you’ve learned on the IG platform.
Explore IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
See how trading works before risking real money
IG’s demo gives you access to thousands of markets and £10,000 in
virtual funds, so you can explore the platform and test your ideas first.
Open an IG demo →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Turn trading theory into practical experience
Learn with IG Academy, explore charts and market tools, and practise
strategies in a simulated trading environment before going live.
Start practising with IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Ready to take your learning further?
IG combines market education, analysis and an established trading platform,
giving you the tools to keep learning as you develop your trading skills.
Discover IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Twelve Bio was spun off from the Novo Nordisk Foundation Centre for Protein Research at the University of Copenhagen and Creation House programme at BioInnovation Institute (BII), an independent biotech incubator.
Analysts were pleased when Arix exited its investment in Quench Bio after a review of initial pre-clinical work was not very promising, which they say was a strong sign that the fund is prepared to “fail quickly”.
One of the keys to successful venture capital investing is to cut losing investments quickly and to focus on portfolio companies that are doing well and could create commercialise their products and services in future.
Naseem Amin, Arix Bioscience’s executive chairman, said: “This has been a period of outstanding achievement for our company. We have begun the journey of turning our promises to shareholders into delivery – realising £158m during the year while at the same time refocusing the portfolio, restructuring and reducing our costs and laying the foundation for the next wave of investments.”
Investors will be watching the company closely to see if some of its portfolio companies make significant breakthroughs that could boost its future earnings.
Arix Bioscience share price.
Arix Bioscience shares rallied 5.4% to trade at 195p after rising from Monday’s closing price of 185p.
